JNJ
Johnson & Johnson
Johnson & Johnson is a diversified pharmaceutical and medical-device giant whose revenue and stock are materially exposed to Medicare drug pricing policy, FDA regulation, and opioid-related litigation.
Govt Dependence
82/100
Regulatory Density
90/100
Lobbying Intensity
78/100
Political Signal
HIGH
BusinessWhat JNJ does
J&J develops and sells branded pharmaceuticals (oncology, immunology, neuroscience) and medical devices across surgery, orthopedics, and vision. Following the 2023 Kenvue consumer-health spinoff, its two core segments are Innovative Medicine and MedTech, with pharma driving the majority of profit.
12 months past · 3 months futureJNJ activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
249 trading days ·
29 congressional trades shown
·
0 insider buys
·
11 13F filings
·
1 past bill actions
·
3 upcoming markups
Executive Branch ConflictsJNJ held by Trump-administration officials
1 cabinet/senior official reported JNJ positions in OGE Form 278 disclosures across 40 filings.
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
JOHNSON & JOHNSON
Donald J. Trump
President · White House
Johnson & Johnson
pharma
Lifetime Government AwardsJNJ federal contracts by year
$689K
total awarded · 2011–2022
14
contracts on file
2022
peak year ($207K)
Top contracts by award amount
$95K
Department of Defense
2011-10-03
STERRAD EQUIPMENT MAINTENANCE
$92K
Department of Defense
2015-02-25
IGF::OT::IGF PREVENTIVE AND CORRECTIVE MAINTENANCE
$65K
Department of Veterans Affairs
2015-03-18
CATHETERS AND CARTO 3 PARTS AND ACCESORIES
$65K
Department of Veterans Affairs
2022-04-28
SCREWS
$53K
Department of Veterans Affairs
2022-01-25
KNEE SCREW
12 years · 14 contracts
Smart Money · 13F HoldingsHedge funds holding JNJ
$165.71B
Total JNJ held by tracked 13F funds
7
Funds with JNJ positions
+1
Funds opened this quarter
Baupost Group
$142.77B
holds
6 overlap
2026-03-31
Two Sigma Investments
$13.02B
+40%
2026-03-31
Soros Fund Management
$8.52B
opened
2026-03-31
Citadel Advisors
$636M
-14%
17 overlap
2025-12-31
Millennium Management
$322M
+56%
2025-12-31
Bridgewater Associates
$272M
-23%
17 overlap
2025-12-31
D.E. Shaw & Co.
$176M
+20%
17 overlap
2025-12-31
Politicians Trading JNJMembers of Congress with recent JNJ positions
24 politicians traded JNJ across 149 disclosed transactions totaling $2.7M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just JNJ). 0-30 LOW · 30-60 MID · 60+ HIGH.
Ro Khanna
24 buys
16 sells
$516K
2026-05-01
LOW · 0
George Whitesides
2 sells
$350K
2025-03-24
LOW · 0
Kevin Hern
2 sells
$350K
2024-12-31
LOW · 1
Jefferson Shreve
4 buys
2 sells
$280K
2025-05-12
LOW · 0
Scott Franklin
6 buys
2 sells
$162K
2025-06-16
LOW · 0
Gilbert Ray Cisneros
4 buys
4 sells
$162K
2025-05-30
HIGH · 61
Thomas H. Kean
7 sells
$154K
2026-06-29
LOW · 2
Josh Gottheimer
12 buys
4 sells
$128K
2025-04-09
LOW · 1
Lisa C. McClain
6 buys
6 sells
$96K
2025-10-31
LOW · 0
Lloyd Doggett
11 buys
$88K
2026-06-09
LOW · 1
Tommy Tuberville
2 sells
$65K
2024-10-29
LOW · 8
Sheri Biggs
2 sells
$65K
2025-03-19
LOW · 0
Pete Sessions
2 sells
$65K
2025-06-12
LOW · 0
Julie Johnson
6 sells
$48K
2025-12-18
LOW · 15
Jared Moskowitz
2 buys
2 sells
$32K
2025-10-10
LOW · 0
9 more politicians active in JNJ · full table in member dashboard
Congressional TradesWho in Congress is trading JNJ
2026-06-29
Thomas H. Kean
Sale
$1,001 - $15,000
2026-06-02
Thomas H. Kean
Sale
$1,001 - $15,000
2026-06-09
Lloyd Doggett
Purchase
$1,001 - $15,000
2026-05-01
Ro Khanna
Sale
$1,001 - $15,000
2026-04-13
Ro Khanna
Purchase
$15,001 - $50,000
2026-03-19
John Boozman
Sale (Partial)
$1,001 - $15,000
2026-03-26
Thomas H. Kean
Sale
$1,001 - $15,000
2026-03-06
Ro Khanna
Sale
$1,001 - $15,000
2026-03-19
Richard McCormick
Sale
$1,001 - $15,000
2026-03-10
Lloyd Doggett
Purchase
$1,001 - $15,000
2026-01-23
Thomas H. Kean
Sale
$15,001 - $50,000
2025-12-18
Julie Johnson
Sale
$1,001 - $15,000
30+ trades on file · most recent 2026-07-16
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting JNJLive legislation impacting this stock
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.1875 · 119th
Medicaid Provider Screening Accountability Act
HR.1867 · 119th
To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnish
HR.1843 · 119th
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HRES.182 · 119th
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
HR.1806 · 119th
Triple-Negative Breast Cancer Research and Education Act of 2025
S.793 · 119th
A bill to amend the Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019 to modify and reauthorize the
S.786 · 119th
Public Health Funding Restoration Act
HR.920 · 119th
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Political ProfileWhere JNJ sits in Washington
bipartisan
Large-cap pharma stocks move materially on drug-pricing legislation, IRA negotiation lists, and FDA/CMS actions; J&J is repeatedly named a loser in price-control bills and a winner in repeal efforts.
Regulatory ExposureThreats & opportunities
Regulatory threats
- Medicare drug price negotiation expansion
- IRA inflation rebates
- opioid litigation liability
- FDA device/biologic tightening
- drug price transparency mandates
Regulatory opportunities
- repeal or narrowing of Medicare price negotiation (S.4953)
- accelerated FDA approval pathways
- patent/exclusivity protections
- medical device tax relief
Capitol Hill AlliesChampions & critics
Congressional champions
- No specific congressional champions identified.
Congressional critics
- Rep. Doggett (D-TX)
- Sen. Warren (D-MA)
LobbyingWho's hired to advocate for JNJ
PhRMAAdvaMedBIOUS Chamber of Commerce
Member intelligence layer
Live signals + predictions for JNJ — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades JNJ
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout JNJ & political exposure
Does Johnson & Johnson (JNJ) hold federal contracts?
Yes. Johnson & Johnson has 14 federal contract awards totaling $688,838, primarily from agencies including Department of Defense, Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own JNJ stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in JNJ on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded JNJ stock?
809 congressional trades by 85 unique members of Congress, most recently on 2026-06-29. See the Congressional Trading panel for politician-by-politician breakdown.
What is JNJ political risk profile?
Government dependence: 82/100. Lobbying intensity: 78/100. Political signal: high. Donor party split: bipartisan.
How does GovGreed track JNJ political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. JNJ data is updated daily from these official federal sources.